Self-Assembling Lauroylated Antimicrobial Peptide with Superior Antimicrobial Activity, Stability, and Selectivity

Area of Science:

• Biotechnology
• Materials Science
• Infectious Diseases

Background:

• Antimicrobial peptides (AMPs) show promise against antibiotic-resistant bacteria but suffer from toxicity and instability.
• Developing stable and safe AMPs is crucial for therapeutic applications.

Purpose of the Study:

• To design and evaluate core-shell nanoparticles as a stable and safe alternative to traditional AMPs.
• To investigate the antimicrobial efficacy, mechanism of action, and therapeutic potential of the lead nanoparticle, GV2.

Main Methods:

• Self-assembly of an imperfectly amphipathic peptide with fatty acids to form core-shell nanoparticles.
• Assessment of antibacterial efficacy against planktonic and biofilm bacteria, including resistance development.
• Mechanistic studies on bacterial membrane interaction and in vivo wound infection models.

Main Results:

• The lead nanoparticle, GV2, exhibited enhanced antibacterial efficacy, safety, and stability compared to the nonassembled peptide.
• GV2 demonstrated rapid bactericidal activity against planktonic and biofilm bacteria without inducing resistance.
• Mechanism involves targeting lipopolysaccharide (LPS), lipoteichoic acid (LTA), and phosphatidylglycerol (PG) in bacterial membranes.
• GV2 showed therapeutic potential in protecting against skin wound infections.

Conclusions:

• GV2 represents a promising, stable, and safe antimicrobial candidate for treating bacterial infections.
• The study provides a strategic framework for designing improved AMP-based therapeutics.
• Nanoparticle formulation overcomes limitations of traditional AMPs, offering a viable clinical strategy.